共 50 条
- [42] THE BENEFIT AND RISK OF HIGH-DOSE METOCLOPRAMIDE IN COMPARISON TO HIGH-DOSE HALOPERIDOL OR TRIFLUPROMAZINE IN CISPLATIN-INDUCED EMESIS KLINISCHE WOCHENSCHRIFT, 1985, 63 (09): : 428 - 432
- [43] PHARMACOKINETIC STUDIES OF HIGH-DOSE METOCLOPRAMIDE WITH AND WITHOUT FORCED DIURESIS KLINISCHE WOCHENSCHRIFT, 1985, 63 (12): : 572 - 574
- [44] HIGH-DOSE METOCLOPRAMIDE FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (09): : 1282 - &
- [45] TARDIVE-DYSKINESIA ASSOCIATED WITH HIGH-DOSE INTRAVENOUS METOCLOPRAMIDE NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (08): : 518 - 518
- [47] RANDOMIZED COMPARISON OF THE ANTIEMETIC EFFICACY OF A SEROTONIN TYPE-3 RECEPTOR ANTAGONIST (MDL 72,222) WITH A HIGH-DOSE METOCLOPRAMIDE REGIMEN AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (02): : 175 - 179
- [48] Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting Supportive Care in Cancer, 1998, 6 : 233 - 236